{'fraction_non_alphanumeric': 0.031484257871064465, 'fraction_numerical': 0.0029985007496251873, 'mean_word_length': 5.128440366972477, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
White House Nominates New FDA Chief

The longtime acting head of the Food and Drug Administration (FDA) has been nominated for the agency's top post. Lester Crawford, a 66-year-old pharmacologist and veterinary medicine specialist, served as FDA's deputy commissioner during the brief tenure of Mark McClellan and has been acting commissioner since then. But some agency watchdogs have criticized his leadership. “We strongly oppose” his nomination, says Sidney Wolfe, director of the health research group Public Citizen in Washington, D.C., who cites Crawford's delays in removing the diet drug ephedra from the market and slapping warnings on the painkiller Vioxx.